EPIX THERAPEUTICS DIAMONDTEMP¿; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
|
Back to Search Results |
|
Model Number CEDTB400L |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Chest Pain (1776); Low Blood Pressure/ Hypotension (1914); Cardiac Tamponade (2226); Pericardial Effusion (3271)
|
Event Date 03/15/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Event Description
|
It was reported that approximately five months following a radiofrequency (rf) ablation procedure, the patient developed recurrent atrial fibrillation (af).An electrocardiogram (ecg) was performed and it was observed that the patient also had an atrial flutter.The physician noted that the atrial flutter was not related the previous ablation and not related to the previous ablation devices.Approximately three months after the recurrent atrial fibrillation (af) was diagnosed, the patient had another radiofrequency (rf) ablation procedure.After the procedure was completed, the patient had chest pain and felt sick.The patient had hypotension and a pericardial effusion and tamponade were identified via electrocardiogram (ecg).Pericardiocentesis was performed.Anti-inflammatory medication was given.The physician noted that the pericardial effusion was probably due to the manipulation of the other diagnostic catheters.The patient's hospitalization was extended.The patient is a participant in a clinical study.No further patient complications have been reported as a result of this event.
|
|
Search Alerts/Recalls
|
|
|